VULVAR MELANOMA
Clinical trials for VULVAR MELANOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR MELANOMA trials appear
Sign up with your email to follow new studies for VULVAR MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to prevent rare melanoma recurrence
Disease control OngoingThis phase II trial tests whether adding cabozantinib to the immunotherapy drug nivolumab can prevent mucosal melanoma from returning after surgery. About 101 patients with resected mucosal melanoma will receive either nivolumab alone or nivolumab plus cabozantinib. The study aim…
Matched conditions: VULVAR MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New dye could replace radioactive tracers in vulvar cancer surgery
Diagnosis OngoingThis study tests whether a dye called indocyanine green (ICG) used with near-infrared imaging can find sentinel lymph nodes as well as the standard radioactive tracer method in people with early-stage vulvar cancer. About 22 participants will receive both methods during surgery t…
Matched conditions: VULVAR MELANOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:56 UTC